Covidien plc (NYSE: COV) has acquired medical device maker Sapheon Inc. for an undisclosed amount.
Sapheon, headquartered in Morrisville, North Carolina, develops and manufactures the VenaSeal system, which is used to treat patients with varicose veins.
Covidien says that the acquisition will help it to provide more treatment options for doctors.
In June, Medtronic Inc. agreed to buy Covidien in a $42.9 billion deal.
The Dublin-based medical device company won Mergers & Acquisitions M&A Mid-Market Strategic Buyer of the Year award for 2012 after scooping up a bunch of medical device companies.